Bioteque Common Stock

The latest common stock for 4107.TWO is $690M as of June 2026. That compares with $690M in the prior-year period — up 0.0% year over year. Investors often review this figure alongside Bioteque's historical trend and sector peers before judging valuation or financial health.

Over the past year, 4107.TWO's common stock moved from $690M to $690M — essentially flat versus a year earlier. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bioteque's operating scale or balance-sheet position.

A common stock figure of $690M for 4107.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 4107.TWO's common stock ($690M), review year-over-year change from $690M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.